Antiarrhythmic Drugs

Presents highly practical information, written in a quick-access, no-nonsense format

Emphasis is on a just-the-facts clinical approach, heavy on tabular material, light on dense prose Involvement of the ISCP will ensure that the best quality contributors will be involved and establish a consistent approach to each topic in the series

Autorentext

A Martinez Rubio, is Chief of Cardiology in the Univ. Hospital of Sabadell and professor of Medicine at the Univ. Autònoma of Barcelona, Spain
J Tamargo is professor of Pharmacology at the School of Medicine of the Univ. Complutense of Madrid, Spain
G. Andrei Dan is Prof of Medicine at the Carol Davila University of Medicine, chief of the Internal Medicine Clinic and of Cardiology Department, Colentina University Hospital, Bucharest, Romania, immediate past President of ISCP

Zusammenfassung

Inhalt
Introduction: Cardiac arrhythmias a clinical problem.- Electrophysiological basis of the arrhythmias.- Class I antiarrhythmic drugs (Na+ channel blockers).- Potassium-channel blockers.- Betablockers.- Modulation of calcium handling/Calcium-channel modulators.- Other antiarrhythmic drugs: Novel targets for AADs.- Non-antiarrhythmic drugs with antiarrhythmic effects.- Clinical management of the arrhythmias.